About RLS Radiopharmacies
RLS Radiopharmacies is a company based in Miami (United States) founded in 2018 was acquired by Telix Pharma in September 2024. It operates as a Professional Services, and Reseller / Distribution. RLS Radiopharmacies offers products and services including SPECT Pharmaceuticals, PET Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals.
- Headquarter Miami, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rls (Usa) Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Telix Pharma
(Sep 23, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RLS Radiopharmacies
RLS Radiopharmacies offers a comprehensive portfolio of products and services, including SPECT Pharmaceuticals, PET Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
SPECT pharmaceuticals are provided for nuclear imaging purposes.
PET radiopharmaceuticals are offered for molecular imaging procedures.
Therapeutic radiopharmaceuticals are supplied for cancer treatment purposes.
Unlock access to complete
Funding Insights of RLS Radiopharmacies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RLS Radiopharmacies
RLS Radiopharmacies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RLS Radiopharmacies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RLS Radiopharmacies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rls Radiopharmacies Comparisons
Competitors of RLS Radiopharmacies
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about RLS Radiopharmacies
When was RLS Radiopharmacies founded?
RLS Radiopharmacies was founded in 2018.
Where is RLS Radiopharmacies located?
RLS Radiopharmacies is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Who is the current CEO of RLS Radiopharmacies?
Werner Gruner is the current CEO of RLS Radiopharmacies.
What does RLS Radiopharmacies do?
RLS Radiopharmacies is involved in the distribution of radiopharmaceuticals, including SPECT, PET, and therapeutic products, across the United States. The company operates a network of 29 pharmacies in 19 states, designed to meet industry standards and led by experienced nuclear pharmacists. Solutions are tailored to provide flexibility, with a focus on aiding physicians in diagnosing and treating life-threatening conditions through precise radiation doses. As part of Telix Pharmaceuticals, RLS continues to uphold excellence as the only Joint Commission-accredited nationwide radiopharmacy network.
What products or services does RLS Radiopharmacies offer?
RLS Radiopharmacies offers SPECT Pharmaceuticals, PET Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals.
Who are RLS Radiopharmacies's investors?
RLS Radiopharmacies has 1 investor. Key investors include Telix Pharmaceuticals.